Evaluation of our first–year endoscopic retrograde cholangiopancreatography results

Özet

Introduction: In this study, the results of the first year of endoscopic retrograde cholangiopancreatography(ERCP), which has been started to be performed in our center, have been evaluated.Materials and Methods: A retrospective analysis was carried out with data of 345 patients who underwentERCP performed by the same team at a single center between April 2019 and April 2020. The patients wereassessed for demographic data, indications for the procedure, procedure–related complications, endoscopic findings and interventions.Results: A total of 345 patients underwent the procedure, with a total of 412 procedures were performed.The patient group comprised 210 women and 135 men, with a mean age of 56.4 (19–86) years. The meanduration of the procedure was 12 (4–48) minutes. The most common (60.4%) indications for ERCP wereradiologically detected ductus choledochus stones and elevated liver enzymes and/or hyperbilirubinemia.Successful cannulation was performed using a standard sphincterotome in a total of 370 procedures. Thenumber of procedures performed using a precut needle–knife sphincterotome was 28; however, cannulationwas successful only in 16. The total cannulation rate was 93.6%. The most common complication (2.9%)was post–ERCP pancreatitis and 30 (7.2%) patients developed post–ERCP complications.Conclusion: Endoscopic retrograde cholangiopancreatography is an endoscopic method commonly usedfor the treatment of pancreaticobiliary diseases. We believe that it should be applied as a therapeutic procedure rather than as a diagnostic tool, being an invasive procedure.